Colorectal Cancer chemotherapy protocols and prescriptions

Blank Chemotherapy Prescriptions

Included are blank chemocare regimen specific prescription files to be used as a part of local Trust contingency plan if the Chemocare Network Systems are not available. Network Chemocare Blank Colorectal Cancer Prescription templates zip folder click here. Last updated 20.12.2017.

Chemotherapy Protocols

The documents below are the NHS England, Area Team’s approved protocols for the management of patients receiving chemotherapy for Colorectal Cancers. All prescribing, preparation, dispensing and administration of chemotherapy should be within a framework of safe practice. Documents to support this framework are available from the Network Chemotherapy Group pages

No Regime Name Valid Until Protocol
CR001 FOLFIRI March 2021 Download
CR002 Weekly Irinotecan March 2021 Download
CR003 Irinotecan three weekly March 2021 Download
CR004 Weekly 5FU and Folinic acid March 2021 Download
CR005 MAYO 5FU and Folinic acid March 2021 Download
CR006 Mod DeGramont March 2021 Download
CR007 FOLFOX March 2021 Download
CR008 CAPOX (Capecitabine & Oxaliplatin) March 2021 Download
CR009 Capecitabine March 2021 Download
CR010 Lokitch (7 day fluouracil) March 2021 Download
CR012 Raltitrexed March 2021 Download
CR017 CAPIRI (Capecitabine & Irinotecan) March 2021 Download
CR018 Capecitabine with radiotherapy March 2021 Download
CR019 Lonsurf (Trifluridine–tipiracil) August 2019 Download
CR028 Cetuximab with FOLFIRI March 2021 Download
CR030 Cetuximab with FOLFOX March 2021 Download
CR031 Panitumumab + FOLFIRI (1st line) March 2021 Download
CR032 Panitumumab + FOLFOX (1st line) March 2021 Download
Discontinued documents
CR011 UFToral May 2016
CR013 Combat (Mitomycin & Fluouracil) Feb 2016
NCDF Bevacizumab with Capecitabine Feb 2016
NCDF Bevacizumab and FOLFOX Feb 2016
NCDF Bevacizumab and FOLFIRI Feb 2016
NCDF Bevacizumab and De Gramont Feb 2016
NCDF Bevacizumab and XELOX Feb 2016
NCDF Bevacizumab and XELIRI Feb 2016
NCDF 2 weekly Cetuximab with Irinotecan Apr 2016
NCDF Single Agent Cetuximab (3rd Line) Apr 2016
NCDF Cetuximab with DeGramont (1st line) Apr 2016
NCDF Aflibercept Feb 2016